Correlation Between Genscript Biotech and Roivant Sciences
Can any of the company-specific risk be diversified away by investing in both Genscript Biotech and Roivant Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genscript Biotech and Roivant Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genscript Biotech and Roivant Sciences, you can compare the effects of market volatilities on Genscript Biotech and Roivant Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genscript Biotech with a short position of Roivant Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genscript Biotech and Roivant Sciences.
Diversification Opportunities for Genscript Biotech and Roivant Sciences
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Genscript and Roivant is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Genscript Biotech and Roivant Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roivant Sciences and Genscript Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genscript Biotech are associated (or correlated) with Roivant Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roivant Sciences has no effect on the direction of Genscript Biotech i.e., Genscript Biotech and Roivant Sciences go up and down completely randomly.
Pair Corralation between Genscript Biotech and Roivant Sciences
Assuming the 90 days horizon Genscript Biotech is expected to under-perform the Roivant Sciences. But the pink sheet apears to be less risky and, when comparing its historical volatility, Genscript Biotech is 1.74 times less risky than Roivant Sciences. The pink sheet trades about -0.01 of its potential returns per unit of risk. The Roivant Sciences is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 128.00 in Roivant Sciences on August 25, 2024 and sell it today you would earn a total of 140.00 from holding Roivant Sciences or generate 109.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 31.99% |
| Values | Daily Returns |
Genscript Biotech vs. Roivant Sciences
Performance |
| Timeline |
| Genscript Biotech |
| Roivant Sciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Genscript Biotech and Roivant Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genscript Biotech and Roivant Sciences
The main advantage of trading using opposite Genscript Biotech and Roivant Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genscript Biotech position performs unexpectedly, Roivant Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roivant Sciences will offset losses from the drop in Roivant Sciences' long position.| Genscript Biotech vs. Telix Pharmaceuticals Limited | Genscript Biotech vs. Keros Therapeutics | Genscript Biotech vs. Zentalis Pharmaceuticals Llc | Genscript Biotech vs. Innovent Biologics |
| Roivant Sciences vs. Roivant Sciences | Roivant Sciences vs. Jasper Therapeutics | Roivant Sciences vs. Humacyte | Roivant Sciences vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |